Indicated for: insomnia
Route of administration: oral
Substance: amobarbital (sedative-hypnotic)
ATC: N05CA02 (Nervous system | Hypnotics and sedatives | Barbiturates, plain)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may cause dependence or be misused.
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol during treatment.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
Amobarbital is a medication from the barbiturate class, primarily used as a sedative, hypnotic, and in some cases, as an anticonvulsant agent. It works by enhancing the effect of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter that reduces excessive brain activity, thereby inducing relaxation, sleep, or seizure control.
Amobarbital is administered orally or intravenously, depending on the indication and the patient's condition. Its use is typically limited to short periods, as it can cause dependence and tolerance.
Common side effects include drowsiness, dizziness, confusion, and respiratory depression. In rare cases, severe adverse reactions such as hypotension, allergic reactions, or withdrawal symptoms upon abrupt discontinuation may occur.
Amobarbital should be used with caution, particularly in patients with respiratory, liver, or kidney conditions. Additionally, it interacts with other medications, such as alcohol or sedatives, which can increase the risk of adverse effects. It is essential that amobarbital use is strictly supervised by a specialist physician to minimize the risks associated with this potent medication.